Carsten Timpe

Roche (Switzerland)

Papers

2

Total Citations

17

H-Index

2

About

Carsten Timpe is a researcher at the forefront of pediatric pharmaceutical science, specializing in the development of child-friendly solid oral dosage forms. His work addresses a critical challenge in medicine: improving the swallowability and acceptability of drugs for children, particularly those requiring combination therapies. Timpe’s key contributions include the design of a novel soft robotic pediatric in vitro swallowing device, which simulates the biomechanics of a child’s swallow to evaluate how mini-tablets perform in the throat. This innovative tool, detailed in his 2022 paper (13 citations), provides a groundbreaking method for predicting swallowability without human trials. He further advanced the field by demonstrating that binary mixtures of mini-tablets with pellets can significantly enhance swallowability, as shown in his 2023 study (4 citations). By focusing on multiparticulate systems as alternatives to unpalatable liquid formulations, Timpe is helping to make pediatric dosing safer, more effective, and more acceptable. His work is pivotal for the design of age-appropriate medicines, directly impacting the development of combination products that improve treatment adherence and outcomes for young patients.

Research Focus

Key Achievements

2
H-Index
2
Papers
17
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
A novel soft robotic pediatric in vitro swallowing device to gain insights into the swallowability of mini-tablets
13 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Roche (Switzerland)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 18 days ago